BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AZD5148 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of AZD5148\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07285213-11172@assetmemo.bio
DTSTAMP:20261121T004549Z
DTSTART;VALUE=DATE:20270420
DTEND;VALUE=DATE:20270421
SUMMARY:AZD5148: Phase 2 readout est. (NCT07285213)
DESCRIPTION:AZD5148\, phase 2.\nStudy: Prevention of Recurrent C. Difficile
  Infection Study With AZD5148 Monoclonal Antibody\nEstimated primary compl
 etion: 20 April 2027. This is a ClinicalTrials.gov estimate\, not a confir
 med readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug
 /azd5148#upcoming-events\nRegistry record: https://clinicaltrials.gov/stud
 y/NCT07285213
URL:https://assetmemo.bio/drug/azd5148#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
